Men treated for prostate cancer often have unexpected outcomes despite predictive models based on stage, grade and prostate-specific antigen (PSA). Previous results have indicated that nuclear morphometry can predict patient outcome in urologic malignancies. Application of this analytical method in
Ductal adenocarcinoma of the prostate : Clinical features and implications after local therapy
β Scribed by Shi-Ming Tu; Adriana Lopez; Dan Leibovici; Mehmet A. Bilen; Ferhat Evliyaoglu; Ana Aparicio; Charles C. Guo; Deborah A. Kuban; Marcy M. Johnson; Louis L. Pisters
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 163 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. This study was performed to evaluate the use of the 1992 International Union Against Cancer (UICC)/American Joint Committee on Cancer (AJCC) T categories for localized prostate cancer treated with radiation therapy and to compare the prognostic power of this system with the Whitmore-Jewe
For the two dysgerminornas in the study by Marx et al. in which overexpression of p53 was detected by LIO-7 and DO-1 in greater than 50% of the tumor cell nuclei, we suggest a further molecular analysis to verify the presence of p.53 mut a t' ion.
## Background: The authors analyzed retrospectively their institution's experience in treating patients with localized prostate carcinoma with external beam radiation therapy (ebrt) to determine the correlation of various biochemical failure (bf) definitions with clinical failure and cause specific
## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmallβcell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,